That’s Nice’s Nice Consulting division offers services as diverse as finding suitable facilities to acquire to providing full-time business development support. The sister service Nice Match is an exclusive community that connects purchasers with suppliers in all phases of pharmaceutical development, helping to find the right relationship to get programs done. Our depth of knowledge from over two decades of connection to the industry supports a full range of strategic agency services.
Life Sciences
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Guy Tiene
PCI Pharma Services’ Ireland Site Prepared in Advance to Meet European Serialization Requirements
Latest investment in initiative to offer serialization services across PCI’s global network. Contract manufacturer PCI Pharma Services initially announced its global serialization initiative in February 2017. Since then, the company has implemented serialization capabilities at sites in the US and Europe, including the installation of state-of-the-art equipment and a flexible and seamless data exchange system backed by skilled and trained serialization teams.
Q: What Role has M&A Played in your Company’s Growth?
— Mergers & Acquisitions — William D. Barbo Corporate Executive Vice President & Chief Commercial Officer, Charles River Laboratories A: M&A has been a significant part of our growth strategy for a number of years. As an organization, we believe that growth is an integral part of being an industry leader.
Q: How important are international partnerships (with sponsor firms, service providers, engineering firms, equipment vendors, raw material suppliers, etc.) to your success?
International Partnerships Ashleigh Wake, Director of Biological Services, Intertek Pharmaceutical ServicesA: Success in international markets is fundamental to the progression and growth of our pharmaceutical business. This demographic is driven by the geography of the market itself, in terms of current global pharmaceutical consumption and predicted regional growth, as well as the regulatory requirement for regional testing to support global and local product registration.
Mergers & Acquisitions: Combining Market Segments
That's Nice Nice Insight Is in Conversation With Dago Caceres, Marketing Director, and Gary Lord, Global Strategic Marketing Director At the Dow Chemical Company, To Discuss the Drivers of The Merger Between Dow and Dow Corning, and the Positive Impact The Move Will Have on Dow’s Pharma Customers. In December 2015, The Dow Chemical Company announced that it would restructure the ownership of Dow Corning, which has shared ownership with Corning for more than seven decades.
Co-Processed Excipients Help Formulate Better OSDs
Co-processed excipients are expected to play a key role in the production of new chemical entities (NCEs), according to BCC Research. As developing new excipients can be time-consuming and expensive from a safety perspective, manufacturers see co-processing of already approved excipients as an attractive alternative.
Lifecycle Management Strategies Can Uncover Hidden Value
The importance of a solid lifecycle management strategy has been long acknowledged in the pharmaceutical industry. However, more emphasis should be put on the entire pharmaceutical product lifecycle — from discovery through the end of life, not only from launch to patent expiry. The entire network of stakeholders including governments, payers, physicians and patients increasingly requires more value for their investments in new therapies.
Spray Drying Enhances Solubility and Bioavailability
It is estimated that at least 40 percent — and possibly as high as 90 percent — of new chemical entities (NCEs) are insufficiently soluble, resulting in low bioavailability and decreased efficacy, according to spray drying services provider, Upperton.1 Spray drying can be an enabling technology when it comes to bioavailability and solubility.
Knowledge, News and Analysis | Pharmaceutical Manufacturing
Lifecycle Management Strategies Can Uncover Hidden Value Pharma companies are recognizing that LCM planning can breathe life into brands, whether pre- or post-launch The importance of a solid lifecycle management strategy has been long acknowledged in the pharmaceutical industry. However, more emphasis should be put on the entire pharmaceutical product lifecycle — from discovery through the end of life, not only from launch to patent expiry.
CDMO Market Continues to Expand
Respondents to Nice Insight’s annual survey of outsourcing-facing pharmaceutical and biotechnology executives expect spending on outsourcing to increase for the fourth year in a row. This result fits well with estimates that the global contract pharmaceutical manufacturing market is growing at an average annual rate of 7.5%.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Guy
Contact Guy, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack